Skip to main content
B

BIDE PHARMATECH CO., LTD. — Investor Relations & Filings

Ticker · 688073 Shanghai Stock Exchange Manufacturing
Filings indexed 480 across all filing types
Latest filing 2022-10-17 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688073

About BIDE PHARMATECH CO., LTD.

Bide Pharmatech Co., Ltd. specializes in the research, development, and supply of high-quality chemical building blocks and specialty reagents for the global pharmaceutical and biotechnology sectors. The company offers an extensive portfolio of small molecule organic compounds, including functionalized heterocycles, catalysts, ligands, and advanced intermediates essential for drug discovery and chemical research. Bide Pharmatech provides comprehensive services ranging from catalog product distribution to custom synthesis and contract research, supporting clients through various stages of the drug development lifecycle. With a focus on technical innovation and rigorous quality control, the firm facilitates efficient lead optimization and process development for academic institutions and commercial laboratories worldwide.

Recent filings

Filing Released Lang Actions
毕得医药-2022年前三季度业绩预告的自愿性披露公告
Regulatory Filings
2022-10-17 Chinese
毕得医药公司章程
Regulatory Filings
2022-10-09 Chinese
毕得医药首次公开发行股票科创板上市公告书
Regulatory Filings
2022-10-09 Chinese
毕得医药首次公开发行股票并在科创板上市发行结果公告
Regulatory Filings
2022-09-28 Chinese
毕得医药首次公开发行股票并在科创板上市招股说明书
Regulatory Filings
2022-09-28 Chinese
毕得医药首次公开发行股票并在科创板上市网下初步配售结果及网上中签结果公告
Regulatory Filings
2022-09-26 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.